JPWO2020039025A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020039025A5
JPWO2020039025A5 JP2021510100A JP2021510100A JPWO2020039025A5 JP WO2020039025 A5 JPWO2020039025 A5 JP WO2020039025A5 JP 2021510100 A JP2021510100 A JP 2021510100A JP 2021510100 A JP2021510100 A JP 2021510100A JP WO2020039025 A5 JPWO2020039025 A5 JP WO2020039025A5
Authority
JP
Japan
Prior art keywords
oxy
sulfonyl
formula
compound
nitrophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021510100A
Other languages
English (en)
Japanese (ja)
Other versions
JP7422741B2 (ja
JP2021535122A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/072467 external-priority patent/WO2020039025A1/en
Publication of JP2021535122A publication Critical patent/JP2021535122A/ja
Publication of JPWO2020039025A5 publication Critical patent/JPWO2020039025A5/ja
Application granted granted Critical
Publication of JP7422741B2 publication Critical patent/JP7422741B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021510100A 2018-08-24 2019-08-22 2-[(3r)-3-メチルモルホリン-4-イル]-4-(1-メチル-1h-ピラゾール-5-イル)-8-(1h-ピラゾール-5-イル)-1,7-ナフチリジンを調製する方法 Active JP7422741B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18190731 2018-08-24
EP18190731.2 2018-08-24
PCT/EP2019/072467 WO2020039025A1 (en) 2018-08-24 2019-08-22 Method for preparing 2-[(3r)-3-methylmorpholin-4-yl]-4-[1-methyl-1h-pyrazol-5-yl)-8-(1h-pyrazol-5-yl)-1,7-naphthyridine

Publications (3)

Publication Number Publication Date
JP2021535122A JP2021535122A (ja) 2021-12-16
JPWO2020039025A5 true JPWO2020039025A5 (es) 2022-08-29
JP7422741B2 JP7422741B2 (ja) 2024-01-26

Family

ID=63405064

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021510100A Active JP7422741B2 (ja) 2018-08-24 2019-08-22 2-[(3r)-3-メチルモルホリン-4-イル]-4-(1-メチル-1h-ピラゾール-5-イル)-8-(1h-ピラゾール-5-イル)-1,7-ナフチリジンを調製する方法

Country Status (26)

Country Link
US (1) US20210253573A1 (es)
EP (1) EP3841101B1 (es)
JP (1) JP7422741B2 (es)
KR (1) KR20210049845A (es)
CN (1) CN112823158B (es)
AU (1) AU2019324521A1 (es)
BR (1) BR112021001309A2 (es)
CA (1) CA3110394A1 (es)
CL (1) CL2021000454A1 (es)
CO (1) CO2021001892A2 (es)
DK (1) DK3841101T3 (es)
ES (1) ES2950825T3 (es)
FI (1) FI3841101T3 (es)
HR (1) HRP20230611T1 (es)
HU (1) HUE062332T2 (es)
IL (1) IL280878A (es)
JO (1) JOP20210032A1 (es)
LT (1) LT3841101T (es)
MX (1) MX2021002132A (es)
PE (1) PE20210862A1 (es)
PL (1) PL3841101T3 (es)
PT (1) PT3841101T (es)
RS (1) RS64362B1 (es)
SG (1) SG11202101011RA (es)
SI (1) SI3841101T1 (es)
WO (1) WO2020039025A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI656121B (zh) 2014-08-04 2019-04-11 德商拜耳製藥公司 2-(嗎啉-4-基)-1,7-萘啶
CA3071760A1 (en) 2017-08-04 2019-02-07 Bayer Pharma Aktiengesellschaft Combination of atr kinase inhibitors and pd-1/pd-l1 inhibitors
US11236070B2 (en) 2019-05-16 2022-02-01 Novartis Ag Chemical process

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2645583A1 (en) * 2006-03-20 2007-09-27 F. Hoffman-La Roche Ag Methods of inhibiting btk and syk protein kinases
JP2010529031A (ja) 2007-05-29 2010-08-26 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー Pi3キナーゼ阻害剤としてのナフチリジン誘導体
EA201100426A1 (ru) 2008-09-02 2011-10-31 Новартис Аг Бициклические ингибиторы киназы
MX349366B (es) 2011-05-19 2017-07-26 Centro Nac De Investigaciones Oncologicas (Cnio) Compuestos novedosos.
KR101366368B1 (ko) * 2011-07-08 2014-02-21 주식회사 두산 신규 유기 전계 발광 화합물 및 이를 포함하는 유기 전계 발광 소자
TWI656121B (zh) * 2014-08-04 2019-04-11 德商拜耳製藥公司 2-(嗎啉-4-基)-1,7-萘啶
WO2018153970A1 (en) * 2017-02-24 2018-08-30 Bayer Pharma Aktiengesellschaft Solid forms of 2-[(3r)-3-methylmorpholin-4-yl]-4-(1-methyl-1h-pyrazol-5-yl)-8-(1h-pyrazol-5-yl)-1,7-naphthyridine

Similar Documents

Publication Publication Date Title
WO2001043744A1 (fr) Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
HRP20230611T1 (hr) Postupak za pripravu 2-[(3r)-3-metilmorfolin-4-il]-4-[1-metil-1h-pirazol-5-il)-8-(1h-pirazol-5-il)-1,7-naftiridina
WO2011104591A1 (en) Novel process for the manufacture of dronedarone
CN108947877B (zh) 一种手性β-羟基砜及其制备方法
WO2005044805A1 (fr) Procede d'elaboration de donepezil et de ses derives
EA004208B1 (ru) Способ получения амлодипина бензолсульфоната
JPWO2020039025A5 (es)
US20200407377A1 (en) Process for the preparation of crisaborole in a stable crystal form
HUE028730T2 (en) Process for the preparation of etoricoxib
RU2021106928A (ru) Способ получения 2-[(3r)-3-метилморфолин-4-ил]-4-(1-метил-1h-пиразол-5-ил)-8-(1h-пиразол-5-ил)-1,7-нафтиридина
EP2928472B1 (en) Process for making reverse transcriptase inhibitors
JP5305593B2 (ja) 高化学的r−5−(2−(2−エトキシフェノキシエチルアミノ)プロピル)−2−メトキシベンゼンスルホンアミド塩酸塩の調製
CA2468426A1 (en) Process for preparing n-(4'-cyano-3'-trifluoromethylphenyl)-3-(4"-fluorophenylsulfonyl)-2-hydroxy-2-methylpropionamide
RU2204564C2 (ru) Способ получения производного дезоксиуридина
NZ521475A (en) A process for preparing biphenyl compounds
JPH06220006A (ja) 新規のアルコキシベンゼンスルホン酸塩
EP2456749B1 (en) Indane derivatives for use as intermediates
EP1424329B1 (en) Process for the preparation of 4-(imidazol-1-yl)benzenesulfonamide derivatives
JP4284755B2 (ja) 1−スルホニルオキシ−2−アルカノール誘導体の製法
WO2008152653A2 (en) An improved process for the preparation of tamsulosin hydrochloride
WO2007132990A1 (en) Process for the preparation of chiral glycidylphthalimide in highly optical purity
KR20060104761A (ko) 레르카니디핀 염산염의 제조 방법
CZ20032354A3 (cs) Příprava N@methylparoxetinu a souvisejících sloučenin jako meziproduktů
CN114409713A (zh) 一种n-非取代二茂铁并吡啶酮衍生物及其合成方法
KR101144776B1 (ko) 광학 활성 벤젠설폰아마이드 유도체의 제조방법